Sielo Robotics

Cover Block

PUBLIC

Name	Sielo Robotics
Tagline	Developing wheelchair-mounted robotic arms to increase independence for non-ambulatory people with upper-limb mobility limitations.
Headquarters	Ottawa, Canada
Founded	2025
Stage	Pre-Seed
Business Model	Hardware + Software
Industry	Deeptech
Technology	Robotics
Geography	North America
Growth Profile	Social Enterprise
Founding Team	Co-Founders (2)
Funding Label	Pre-seed
Total Disclosed	$243,000 [Marketcast]

Links

PUBLIC

• Website: https://www.sielorobotics.com/
• LinkedIn: https://www.linkedin.com/company/sielo-robotics/

Note: The LinkedIn company profile is referenced in the raw research snippets and is the source for multiple team member profiles. No other social media handles, GitHub repositories, or app store listings are confirmed by the available sources.

Executive Summary

PUBLIC

Sielo Robotics is a pre-seed Canadian startup developing a wheelchair-mounted robotic arm designed to restore independence for non-ambulatory individuals with limited upper-limb mobility, a market segment where existing assistive technology remains prohibitively expensive and clinically focused. The company originated from a student engineering project at the University of Ottawa, where the founding team worked directly with end-users, Charlotte and Sienna, to co-design the initial prototype [University of Ottawa]. Its core product, a robotic arm that mounts to standard power wheelchairs, is positioned to enable activities of daily living like eating and retrieving objects without caregiver assistance, differentiating itself by targeting personal, at-home use rather than institutional settings [Perplexity Sonar Pro Brief]. The founding team, led by Laila Burns and Lucy Amos, appears to be young and technically oriented, with backgrounds emerging from the university's engineering ecosystem and student entrepreneurship programs like Enactus Canada [Enactus Canada, April 2024]. To date, the company has raised $243,000 via an SEC Form D filing, capital that appears directed toward continued R&D and prototype refinement as the venture remains pre-commercial with no cleared product or public pricing [Marketcast]. Over the next 12-18 months, the critical milestones to track will be the transition from prototype to a market-ready device, the initiation of regulatory clearance processes with Health Canada or the FDA, and the establishment of initial pilot partnerships with wheelchair OEMs or care institutions.

Data Accuracy: YELLOW -- Core product claims are sourced from the company and third-party profiles; funding data is from a single public filing; team details are inferred from social media and LinkedIn.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	Hardware + Software
Industry / Vertical	Deeptech
Technology Type	Robotics
Geography	North America
Growth Profile	Social Enterprise
Founding Team	Co-Founders (2)
Funding	Pre-seed (total disclosed ~$243,000)

Company Overview

PUBLIC

Sielo Robotics formed in 2025 as a Canadian assistive technology company focused on developing wheelchair-mounted robotic arms. The venture originated from a student project within the University of Ottawa’s Faculty of Engineering GNG2102 engineering design course, where the initial concept for a robotic arm to aid motorized wheelchair users was developed [University of Ottawa]. The company’s public narrative emphasizes co-design with potential users, noting its team was matched with two young women whose experiences helped shape the product direction [University of Ottawa].

Headquartered in Ottawa, the company operates as Sielo Robotics Inc. Its public presence is anchored by a website outlining the mission and a privacy policy listing an internal contact, evan@sielorobotics.com, for data protection queries [Sielo Robotics]. The company has been recognized by regional innovation hubs, appearing as a client profile on the website of Ontario’s Innovation Factory, which describes its focus on wheelchair-mounted robotic arms [Innovation Factory].

A key early milestone is a disclosed capital raise of $243,000, filed via an SEC Form D [Marketcast]. This pre-seed level of funding, coupled with the absence of any marketed product or regulatory clearance announcements, places the company in a pre-commercial, research and development phase. There is no public record of a product launch, named commercial partnerships, or regulatory approvals as of this report.

Data Accuracy: YELLOW -- Core company description and funding amount are cited; founding details rely on university sources; team roles and full capitalization are not publicly verified.

Product and Technology

MIXED Sielo Robotics is developing a single, integrated hardware and software product: a wheelchair-mounted robotic arm (WMRA) designed to restore autonomy for a specific user group. The device is intended to mount directly to a user's existing power wheelchair using standard attachment brackets, a design choice that suggests a focus on accessibility and retrofit rather than requiring a custom mobility platform [Sielo Robotics]. Its core function is to enable users to perform activities of daily living, such as eating, drinking, and retrieving objects, without requiring caregiver assistance [Perplexity Sonar Pro Brief].

The product's development originated in a university engineering design course, where the founding team was paired with two young women with limited mobility, indicating a co-design approach from the outset [University of Ottawa]. Public descriptions of the arm as "AI-powered" [Enactus Canada, April 2024] point to a software layer, likely for control interfaces like voice commands, gaze tracking, or switch access, though the specific implementation is not detailed. The company's current hiring for a robotics software engineer [LinkedIn, 2026] supports the inference that software development for intuitive user control is a central component of the technology stack.

A critical, publicly visible gap is the absence of any commercial product specifications, regulatory clearance status, or pricing. The website and ecosystem profiles describe the mission and intended use cases but do not showcase a finalized, market-ready device [Perplexity Sonar Pro Brief]. This places the company firmly in a pre-commercial, likely prototype-refinement phase, with significant engineering and certification work ahead before a product can be shipped to end-users.

Data Accuracy: YELLOW -- Core product claims are consistent across multiple sources, but technical specifications and development stage are inferred from limited public data.

Market Research

PUBLIC

The market for assistive robotics is being reshaped by demographic pressure, a persistent gap in caregiver capacity, and a growing emphasis on user autonomy over institutionalization.

Quantifying the total addressable market for wheelchair-mounted robotic arms (WMRAs) is challenging due to the nascent state of the category and the lack of dedicated third-party sizing reports. Analysts often triangulate using adjacent markets. The global market for all assistive robots, including those for rehabilitation and personal care, was valued at approximately $1.2 billion in 2023 and is projected to reach $2.6 billion by 2028, according to a report from MarketsandMarkets [MarketsandMarkets]. This broader category includes hospital-based exoskeletons and surgical robots, making it an imperfect but indicative analog. More directly, the global power wheelchair market itself is a multi-billion dollar industry, with Grand View Research estimating its size at $4.7 billion in 2023 [Grand View Research]. The SAM for Sielo Robotics would be a subset of this population: power wheelchair users who also have limited upper-limb function. Published epidemiological studies suggest this could represent a significant portion of the estimated 3.3 million power wheelchair and scooter users in the United States alone [CDC].

Assistive Robots (Global) 2023 | 1.2 | $B
Assistive Robots (Global) 2028 | 2.6 | $B
Power Wheelchairs (Global) 2023 | 4.7 | $B

The chart underscores the substantial baseline of the mobility market and the projected growth within assistive technology, though it does not isolate the specific WMRA segment. The growth trajectory suggests a receptive environment for innovative solutions that can command premium pricing by addressing acute user needs.

Demand is driven by several converging forces. An aging global population is increasing the prevalence of conditions like spinal cord injuries, ALS, and multiple sclerosis that can lead to upper-limb impairment [WHO]. Concurrently, a well-documented shortage of professional and informal caregivers creates a supply crisis, making technologies that reduce dependency not just desirable but economically necessary [Home Care Association of America]. There is also a pronounced shift in care philosophy, supported by legislation like the Americans with Disabilities Act, favoring independent living and community integration over institutional care, which aligns perfectly with a device designed for personal, daily use in the home [U.S. Department of Justice].

Regulatory pathways and reimbursement models present both a barrier and a potential catalyst. In North America, devices like Sielo's would typically require clearance from Health Canada or the U.S. Food and Drug Administration (FDA) as Class II medical devices, a process that demands rigorous clinical validation and adds significant time and cost to development [FDA]. Successfully navigating this can create a durable moat. The larger commercial hurdle, however, may be securing coverage from public and private insurers. While some existing assistive robotic arms have obtained reimbursement codes, adoption is not yet widespread, and demonstrating measurable outcomes in reducing caregiver hours or improving user health will be critical for payor acceptance [CMS].

Data Accuracy: YELLOW -- Market sizing relies on analogous, broader category reports; specific WMRA data is not publicly available. Demand drivers are supported by established institutional reports.

Competitive Landscape

MIXED Sielo Robotics enters a specialized niche defined by high-cost, low-volume medical hardware, where the primary competition comes from established assistive robotics manufacturers rather than general-purpose startups.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Sielo Robotics	Wheelchair-mounted robotic arm for personal ADLs, targeting power wheelchair users.	Pre-seed; $243k disclosed.	Focus on direct integration with existing power wheelchairs; co-design approach with end-users noted in early development.	[Sielo Robotics]
Kinova (Jaco)	Robotic manipulator arm for assistive applications, mounted on wheelchairs or tables.	Established; part of larger robotics portfolio.	Long-standing brand in assistive robotics; multiple control interfaces (joystick, chin control, sip-and-puff).	[Kinova Robotics]
Exact Dynamics (iARM)	Desktop-mounted robotic arm for individuals with limited upper-limb function.	Commercial product; specific funding not detailed.	Desktop form factor for stationary use; marketed for home, office, and educational environments.	[NIBIB]

The competitive map for wheelchair-mounted assistive devices is narrow. Incumbents like Kinova have over a decade of market presence and regulatory clearance, selling primarily through clinical and durable medical equipment channels [IEEE Spectrum]. There are few direct challengers in the WMRA segment, reflecting the significant barriers to entry in medical device development. Adjacent substitutes include non-robotic assistive tools, such as reachers and custom mouth-operated devices, which compete on price and simplicity but lack the functional range of a robotic arm.

Sielo's current edge appears to be its specific design focus on smooth integration with personal power wheelchairs, a detail emphasized in its materials [Sielo Robotics]. The company's origin in a university engineering project involving co-design with end-users, referenced as Charlotte and Sienna, suggests an early commitment to user-centered design that could inform product-market fit [University of Ottawa]. This focus is perishable, however, as it relies on execution speed and capital to translate early user feedback into a certified, manufacturable product before incumbents can adapt or new entrants emerge.

The company is most exposed to Kinova's entrenched advantages. Kinova possesses an established regulatory pathway, an existing sales and support network within the assistive technology ecosystem, and a product with a documented track record of use [IEEE Spectrum]. Sielo has no publicly disclosed partnerships with wheelchair OEMs or distributors, a critical gap for a hardware-dependent go-to-market strategy. Furthermore, the absence of any public pricing or regulatory status places Sielo in a pre-commercial position, while its competitors are already commercial entities [Perplexity Sonar Pro Brief].

The most plausible 18-month scenario hinges on Sielo's ability to secure non-dilutive grant funding or a strategic partnership to fund a pivotal clinical pilot. A winner in this scenario would be a company that successfully partners with a major wheelchair manufacturer for integrated distribution, potentially bypassing the traditional clinical sales channel. A loser would be any pre-revenue entrant that fails to secure the capital needed to navigate the lengthy and expensive Health Canada or FDA Class II medical device clearance process, stalling indefinitely in prototype purgatory.

Data Accuracy: YELLOW -- Competitor profiles are confirmed via manufacturer sites and industry reports; Sielo's differentiation claims are from its own materials without third-party validation of technical specs or integration capabilities.

Opportunity

PUBLIC The prize for Sielo Robotics is a durable, high-margin position at the intersection of two multi-billion dollar markets: assistive robotics and power mobility.

The headline opportunity is to become the default, integrated robotic arm for the global power wheelchair market. The outcome is reachable not because of a superior robotic core, but because of a focused integration strategy. The company's device is designed to mount to most power wheelchairs using standard brackets, a deliberate choice that sidesteps the need to build a mobility platform and instead leverages the existing, deeply embedded base of wheelchair OEMs and users [Sielo Robotics]. This positions Sielo not as a standalone robotics company, but as an essential accessory for a pre-existing, highly sticky ecosystem. The evidence that this outcome is more than aspirational lies in the early co-design process; the company's first prototype was developed in direct collaboration with two young women who use power wheelchairs, Charlotte and Sienna, suggesting a product development loop anchored in user need rather than pure engineering capability [University of Ottawa].

Two or three growth scenarios, each named

Scenario	What happens	Catalyst	Why it's plausible
OEM Partnership & Bundling	A major power wheelchair manufacturer (e.g., Permobil, Sunrise Medical) integrates the Sielo arm as a factory-installed or dealer-sold option.	A successful, small-scale pilot with a regional clinic or rehab center demonstrates user adoption and clinical utility.	The assistive robotics market is historically partnership-driven; Kinova's Jaco arm, a key competitor, is often promoted through its relationships with wheelchair providers and rehab institutions [Kinova Robotics]. Sielo's design philosophy of mounting to existing chairs is inherently partnership-friendly.
Insurance Reimbursement Pathway	The device achieves Health Canada/FDA clearance and secures a reimbursement code from a major public or private insurer, unlocking a funded purchase channel.	Completion of a clinical study demonstrating improved user independence and reduced caregiver burden, leading to regulatory approval.	The total addressable market for assistive devices is largely gated by third-party payer systems. Demonstrating clinical and economic outcomes is a well-trodden, if arduous, path to scale in medical technology, as seen with other durable medical equipment [NIBIB].

What compounding looks like The primary compounding mechanism is a data-driven refinement loop. Each deployed unit generates usage data on task frequency, success rates, and failure modes in real-world home environments. This proprietary dataset, cited by the company as a point of differentiation, could be used to train more adaptive control algorithms, improve safety features, and identify the highest-value next-generation functionalities [Enactus Canada, April 2024]. This creates a product moat: the system becomes smarter and more reliable with scale, making it increasingly difficult for a new entrant without deployment history to match its performance. Early signs of this flywheel are present in the company's stated co-design ethos, but the transition from user feedback to structured, operational data collection is the next critical step.

The size of the win A credible comparable is Kinova Robotics, a private Quebec-based company specializing in assistive and lightweight industrial robotic arms. While Kinova does not disclose financials, its Jaco assistive arm has been on the market for over a decade, is featured in clinical research, and represents a proven product category with established pricing in the tens of thousands of dollars per unit [IEEE Spectrum]. If Sielo executes on the OEM Partnership scenario and captures a meaningful share of the North American power wheelchair accessory market,a market comprising hundreds of thousands of units sold annually,the company could approach a valuation comparable to specialized medical device makers. For context, achieving even single-digit penetration of the annual power wheelchair sales funnel could translate to a business with tens of millions in annual revenue. This is a scenario, not a forecast, but it outlines the scale of the outcome if integration and reimbursement hurdles are cleared.

Data Accuracy: YELLOW -- Opportunity framing relies on cited product strategy and market structure; growth scenarios are extrapolated from competitor and industry patterns rather than company-confirmed milestones.

Sources

PUBLIC

1. [University of Ottawa] Student startups at uOttawa: Assistive robotics co-designed by people with limited mobility | https://www.uottawa.ca/en/news-all/student-startups-uottawa-assistive-robotics-co-designed-people-limited-mobility

2. [Perplexity Sonar Pro Brief] What Sielo Robotics does | https://www.perplexity.ai/

3. [Enactus Canada, April 2024] Say hello to Laila Burns and her company, Sielo Robotics! | https://www.facebook.com/EnactusCanada/posts/say-hello-to-laila-burns-and-her-company-sielo-robotics-their-ai-powered-robotic/1501978048605277/

4. [Marketcast] Sielo Robotics Inc. SEC Form D filing summary | https://marketcast.com/

5. [Sielo Robotics] Home | Sielo Robotics | https://www.sielorobotics.com/

6. [Innovation Factory] Sielo Robotics - Company Profile | https://innovationfactory.ca/clients/sielo-robotics/

7. [LinkedIn, 2026] Yugmil Patel - Sielo Robotics | LinkedIn | https://www.linkedin.com/in/yugmilpatel/

8. [MarketsandMarkets] Assistive Robotics Market - Global Forecast to 2028 | https://www.marketsandmarkets.com/

9. [Grand View Research] Power Wheelchair Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/

10. [CDC] Disability and Health Data System (DHDS) | https://www.cdc.gov/

11. [WHO] Ageing and health | https://www.who.int/

12. [Home Care Association of America] Home Care Industry Statistics | https://www.hcaoa.org/

13. [U.S. Department of Justice] Americans with Disabilities Act | https://www.ada.gov/

14. [FDA] Classify Your Medical Device | https://www.fda.gov/

15. [CMS] Durable Medical Equipment (DME) Center | https://www.cms.gov/

16. [Kinova Robotics] Jaco assistive robotic arm | https://assistive.kinovarobotics.com/product/jaco-robotic-arm

17. [IEEE Spectrum] Jaco Is a Low-Power Robot Arm That Hooks to Your Wheelchair | https://spectrum.ieee.org/robot-arm-helps-disabled-11-year-old-girl-show-horse-in-competition

18. [NIBIB] Abstract There are approximately 2.8 million wheelchair ... | https://www.nibib.nih.gov/sites/default/files/R-ARM.pdf